Re: Farmas USA
Re: Farmas USA
With all things considered, Zogenix is a $400 million company, and with the biotechnology industry currently trading at 9.6 times sales, Zogenix won't need much in sales to support its current valuation. With that said, a successful launch will tell us a lot about the demand for this drug, and could catapult shares many times higher if positive. Hence, the launch of Zohydro is my number two most significant watch in biotechnology over the next year.
http://seekingalpha.com/article/2129923-8-biotech-events-to-anticipate-this-year-part-one?ifp=0
hydrocodone is the most prescribed drug in the U.S., with nearly 127 million scripts last year.
Re: Farmas USA
vaya, que ganas por bajarla, 66k shares en pre con minimo en 1,73
AMRN
Re: Farmas USA
IBB
La MA200 está en 219. La tocaremos?. Dedos cruzados.
MACK
Datos buenos de una fase1. Y claro, en rojo. Dita sea!
Re: Farmas USA
tocalaaaaaaaaaa
Re: Farmas USA
Re: Farmas USA
NVAX booom!
:)
edito: es un boom pequeñito, un "boom-ito" , da igual, es VERDE!